BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38194936)

  • 1. Mortality and Lithium-Protective Effects after First-Episode Mania Diagnosis in Bipolar Disorder: A Nationwide Retrospective Cohort Study in Taiwan.
    Carvalho AF; Hsu CW; Vieta E; Solmi M; Marx W; Berk M; Liang CS; Tseng PT; Wang LJ
    Psychother Psychosom; 2024; 93(1):36-45. PubMed ID: 38194936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
    Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
    Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
    Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Lazarus A
    Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
    Hong Y; Huang W; Cao D; Xu J; Wei H; Zhang J; Wang L
    Psychopharmacology (Berl); 2022 Oct; 239(10):3367-3375. PubMed ID: 36063207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
    Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M
    Bipolar Disord; 2018 Mar; 20(2):97-170. PubMed ID: 29536616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
    Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP
    JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
    Suppes T; Vieta E; Gustafsson U; Ekholm B
    Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
    Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
    J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium for acute mania.
    McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Double-Blind, Controlled Trial of Lithium Versus Quetiapine for the Treatment of Acute Mania in Youth with Early Course Bipolar Disorder.
    Patino LR; Klein CC; Strawn JR; Blom TJ; Tallman MJ; Adler CM; Welge JA; DelBello MP
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):485-493. PubMed ID: 34520250
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
    Vitiello B; Riddle MA; Yenokyan G; Axelson DA; Wagner KD; Joshi P; Walkup JT; Luby J; Birmaher B; Ryan ND; Emslie G; Robb A; Tillman R
    J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):867-78. PubMed ID: 22917200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
    Yu CL; Carvalho AF; Thompson T; Tsai TC; Tseng PT; Hsu CW; Hsu TW; Liang CS
    BMJ Ment Health; 2023 Feb; 26(1):. PubMed ID: 36789916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
    Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study.
    Hayes JF; Marston L; Walters K; Geddes JR; King M; Osborn DP
    PLoS Med; 2016 Aug; 13(8):e1002058. PubMed ID: 27483368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
    Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
    Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.